![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HUMAN CONFIRMATION OF ORAL DOSE REDUCTION POTENTIAL OF NANOPARTICLE ANTIRETROVIRAL FORMULATIONS
|
|
|
Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle, WA
Andrew Owen, Steve Rannard, AkilJackson, Laura Dickinson, Marco Giardiello, Marco Siccardi, Paul Domanico, MelyndaWatkins, Yao Cheng, Marta Boffito
WEBCAST:http://www.croiwebcasts.org/console/player/33376?mediaType=slideVideo&
![0301171](../images/030117/030117-6/0301171.gif)
![0301172](../images/030117/030117-6/0301172.gif)
![0301173](../images/030117/030117-6/0301173.gif)
![0301174](../images/030117/030117-6/0301174.gif)
![0301175](../images/030117/030117-6/0301175.gif)
![0301176](../images/030117/030117-6/0301176.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|